ReviewJournal of inflammation research2026
Detrimental and Beneficial Diets Regulate Acute Pancreatitis Through Convergent Gut Microbiota Pathways.
Review in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diet is a key factor in regulating gut microbiota homeostasis, thereby influencing the incidence, severity, and prognosis of acute pancreatitis (AP). This review categorizes common dietary patterns into harmful types (Western diet, high-fat diet, ketogenic diet, high-salt diet) and beneficial types (Mediterranean diet, high-fiber diet, plant-based diet, restricted diet). Unlike previous reviews that list dietary patterns one by one, this paper analyzes them within the framework of the four core pathological/protective pathways of AP. Harmful diets primarily exacerbate AP by inducing dysbiosis, reducing SCFAs (especially butyrate), impairing the gut barrier, promoting bacterial translocation and excessive inflammatory responses; beneficial diets alleviate AP progression by enriching probiotics, increasing SCFA synthesis, enhancing barrier integrity, and suppressing systemic inflammation. This paper particularly emphasizes that most current evidence comes from non-AP models such as obesity and inflammatory bowel disease, and AP-specific causal evidence remains very limited. By integrating clinical, animal, and cellular experimental evidence, this paper aims to elucidate the potential relationship between diet, gut microbiota, and AP, and to provide a theoretical basis for dietary intervention strategies targeting the gut microbiota.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.